Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Cel Sci Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −4 vs. Q3 2021
- Shares held
- 15.6M
- −566.9K (−3.5%) vs. Q3 2021
- Total value
- $110.5M
- −$66.7M (−37.6%) vs. Q3 2021
- New holders
- 16
- 32 more added
- Sold out
- 20
- 27 more reduced
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 40 | $2.08M |
| Q1 2026 | 39 | $2.43M |
| Q4 2025 | 40 | $3.90M |
| Q3 2025 | 35 | $8.01M |
| Q2 2025 | 28 | $1.10M |
| Q1 2025 | 53 | $1.73M |
| Q4 2024 | 62 | $2.75M |
| Q3 2024 | 66 | $6.32M |
| Q2 2024 | 67 | $7.22M |
| Q1 2024 | 78 | $14.5M |
| Q4 2023 | 73 | $17.9M |
| Q3 2023 | 66 | $6.79M |
| Q2 2023 | 61 | $13.2M |
| Q1 2023 | 64 | $13.1M |
| Q4 2022 | 76 | $13.8M |
| Q3 2022 | 78 | $20.0M |
| Q2 2022 | 85 | $34.5M |
| Q1 2022 | 112 | $53.6M |
| Q4 2021 | 103 | $110.5M |
| Q3 2021 | 110 | $177.3M |
| Q2 2021 | 117 | $121.1M |
| Q1 2021 | 115 | $208.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Cel Sci Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,077,882 | $14.8M | 0.00% | −54,359−2.5% | Reduced |
| BlackRock Inc. | 2,942,209 | $20.9M | 0.00% | +75,920+2.6% | Added |
| State Street Corp | 3,368,998 | $23.9M | 0.00% | −1,207,726−26.4% | Reduced |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −46,900−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −52,447−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −21,177−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −21,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,684−100.0% | Sold out |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 0 | $0 | 0.00% | −13,253−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −11,782−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −10,426−100.0% | Sold out |
| Herold Advisors, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Kings Point Capital Management | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Caldwell Trust Co | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −730−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Sterling Financial Planning, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Pflug Koory, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Heritage Wealth Management, LLC | – | – | – | – | Not filed |
| Wealth Quarterback LLC | – | – | – | – | Not filed |
| Sonora Investment Management, LLC | – | – | – | – | Not filed |